Navigation Links
Cyclic Citrullinated Peptide Antibody, IgG

ProductsCyclic Citrullinated Peptide Antibody, IgG
Company ARUP Laboratories
Item Cyclic Citrullinated Peptide Antibody, IgG
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Cyclic AMP, Nephrogenous
2. Cyclic AMP, Plasma
3. Cyclic AMP, Urine
4. Ultrasensitive C-Peptide EIA Diabetes and Obesity Markers 008-10-1141-01
5. C-Peptide EIA Diabetes and Obesity Markers 008-10-1136-01
6. Genetic Systems HIV-1/HIV-2 Peptide EIA
7. C-Peptide
8. ADVIA Centaur C-Peptide Assay
9. C-Peptide Chemiluminescence Immunoassay
10. ACS:180 C-Peptide Assay
11. C-Peptide of Insulin ELISA Test
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products:
(Date:9/5/2008)...e/ -- As the general election,campaign begins in e...nt,Business ( http://www.nfib.com ) is looking to ...s on the healthcare concerns of small,business. No...re over, NFIB,is asking both candidates to fully c...usinesses as they further develop their healthcare...
(Date:9/5/2008)...disease resistance to anti-hormonal therapy , ...ug sorafenib may help "re-sensitize" certain breas...n University Medical Center researchers say. , ...tor positive (ER or PR positive) metastatic breast...as aromatase inhibitors, to keep the cancer under ...
(Date:9/5/2008)...ositive, metastatic breast cancer may take medicat...ut when the tumor becomes resistant to anti-hormon...only option. But a study presented today at the 20...roach. Early data suggests a new treatment approa...monal drugs to do their job once again. , The st...
(Date:9/5/2008)...ek,s Annual Destination to Feature VelaShape. , ... September 5, 2008 -- http://www.americanlaser.co...r], the largest provider of laser hair removal and... announces sponsorship of the STYLE360 show during..., serves as the alternative Fashion Week destinati...
Breaking Medicine News(10 mins):Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 3Health News:Drug Re-Sensitizes Breast Tumors to Treatment 2Health News:1 step back ... 2 steps forward 2Health News:American Laser Centers Sponsors STYLE360 to Share the Skinny on Body Shaping 2
...at low birthweight babies born with low sodium (sa...rge quantities of dietary sodium later in their li...borns with the most severe cases of low sodium blo... per day and weighed some 30 percent more than the...
...s in University at Buffalo Center for Research an...ws that swimmers and scuba divers can improve thei...h targeted training of the respiratory muscles. I...lowed a resistance-breathing training protocol (br...
... result of a subtle marriage between a compound (t... appropriate excipient// (a neutral substance in w...it can be absorbed by the body). Thus the necessar...would happen if biodegradable materials were used ...
...wal, today launched a unique web-based tool design...e, and make hospitals safer for patients and docto... allows doctors to track their work, on-call, recr...ek, and determine whether their work arrangements ...
Other Medicine News:Health News:Low Blood Sodium When Born Linked to Long Term Sodium Intake 2Health News:Low Blood Sodium When Born Linked to Long Term Sodium Intake 3Health News:Training Breathing Muscles Improves Swimmer's Performance 2Health News:Training Breathing Muscles Improves Swimmer's Performance 3Health News:Training Breathing Muscles Improves Swimmer's Performance 4Health News:New Generation - Medicinal Products 2Health News:New Generation - Medicinal Products 3Health News:New AMA Tool Empowers Doctors to Work Safer Hours 2
(Date:9/5/2008)...Extracted From a Simple Blood Draw Have,the Potent...a Wide Range of Indic...Genomics is Currently Developing a B...Israel and JERSEY CITY, New Jersey, September 5,/P...SDQ: ROSG), a leader in,the development of microRN...
(Date:9/4/2008)...eal-time PCR testing for the diagnostic ...ept. 4 /- The U.S. Food & Drug,Admini...Man(R) HBV Test,the first assay for quantitating ...t uses Roche,s real-time PCR technology to quantif...,s blood. Doctors may use viral load,testing resul...
(Date:9/4/2008)...Women at More Than 100 Sites in the U.S., ANN ARB...uticals, a,privately-held biopharmaceutical compan...compounds to treat endocrine, metabolic and,cardio...itiated a second,Phase 3 clinical trial of Ophena(...ree oral therapy in development for the treatment ...
(Date:9/4/2008)...tification for Targeted Therapies Tha...TINGTON BEACH, Calif., and AMSTERDAM, Netherlands,...n molecular cancer diagnostics,today announced th...that,allows physicians to quantitatively determine...or (ER), progesterone receptor (PR) and Human Epid...
Breaking Medicine Technology:Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Crystal 28eye 29 ball 3A Study says visual system equipped with future seeing powers 3326 1Crystal 28eye 29 ball 3A Study says visual system equipped with future seeing powers 3326 2Crystal 28eye 29 ball 3A Study says visual system equipped with future seeing powers 3326 3Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 1Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 2Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 3Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 4Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 5Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 6Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 7Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 8Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 9Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 10Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 11Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 12Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 13Somanetics Corporation to Present at Citigroup 2008 Healthcare Conference 19468 1Somanetics Corporation to Present at Citigroup 2008 Healthcare Conference 19468 2Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2079 1Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2079 2
...ech (ACTI.ST), today,announced new positive clinic...reatment of prostate cancer. , By step-wise dose e...ieved, which corresponds to a doubling of the prev... of 0.5 mg/day. This,means that a step-wise intra-... to be administered in future clinical trials. , "...
...eragenix Pharmaceuticals,Inc. (OTCBB:CGXP), a bio...se and dermatology, today announced that a cathete...irtually no biofilm,formation in a 21 day study., ...Ceragenins,were soaked daily in a phosphate-suffer...ay 21, the catheters were challenged with,an inocu...
Other Medicine Technology:Positive Clinical Data for TASQ - Active Biotech's Novel Treatment,of Prostate Cancer 2Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 2Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 3